Parcar 1 mg Tablet

Manufactured byZydus Cadila
ContainsCabergoline
Description

Parcar 1 mg Tablet is used to treat excess production of a natural hormone called prolactin. Excess production of this hormone is due to unknown causes or abnormal growths in the pituitary. This medicine helps in preventing infertility, sexual problems, and bone loss caused by excess prolactin production in men and in women who are not breastfeeding. It is also used as a second line therapy in the treatment of signs and symptoms of Parkinson's disease along with carbidopa-levodopa or as a single agent in case of failure of or intolerance to a non-ergot compound.

Side effects

Major & minor side effects for Parcar 1 mg Tablet

  • Hypersensitivity
  • Painful menstruation
  • Burning or tingling sensation of hands and feet
  • Breast pain
  • Heartburn
  • Constipation
  • Nausea and vomiting
  • Blurred vision
  • Difficulty in breathing
  • Decrease in frequency of urination
  • Swelling of ankles or feet

Uses of Parcar 1 mg Tablet

What is it prescribed for?

  • Hyperprolactinemia
  • Parkinson's disease
Read More
Concerns

Commonly asked questions

  • Onset of action
    The time required for this medicine to show its action is not clinically established.
  • Duration of effect
    The effect of this medicine lasts for an average duration of 7 to 28 days.
  • Safe with alcohol?
    Alcohol should not be consumed while receiving this medicine since it may increase the risk of dizziness, drowsiness, and difficulty concentrating. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating heavy machinery if alcohol is consumed during treatment with this medicine.
  • Is it habit forming?
    No habit forming tendencies were reported.
  • Usage in pregnancy?
    This medicine is considered safe for consumption by pregnant women. However, all the risks and benefits should be discussed with the doctor before taking this medicine.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women.

Allergy

This medicine is not recommended for use in patients with a known allergy to cabergoline or any ergot alkaloids or any other components present along with it.

Hypertension

This medicine is not recommended for use in patients with uncontrolled hypertension due to the increased risk of serious cardiovascular adverse effects.
Warnings for special population

Pregnancy

This medicine is considered safe for consumption by pregnant women. However, all the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women.
General warnings

Hepatic dysfunction

Caution is advised while using this medicine in patients with liver diseases due to an increased risk of severe adverse effects. Close monitoring of liver functions is advised for such patients.

Use in pediatrics

This medicine is not recommended for use in children.

Lactation suppression

This medicine is not recommended for suppressing milk production due to the increased risk of serious adverse effects such as stroke, hypertension, and seizures.

Missed Dose

Take the missed dose as soon as you remember it. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor immediately in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Alcohol should not be consumed while receiving this medicine since it may increase the risk of dizziness, drowsiness, and difficulty concentrating. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating heavy machinery if alcohol is consumed during treatment with this medicine.
Interaction with Medicine

Clarithromycin

Erythromycin

Sodium oxybate

Lorcaserin

Disease interactions

Cardiac valvular disorders

Use of Parcar 1 mg Tablet in patients with heart valve disorders is not recommended. It is advised to perform a cardiovascular evaluation prior to beginning therapy with this medicine. It is advised that you should inform the doctor about all your medical conditions before beginning treatment with this medicine.

Hypotension

Caution is advised while using this medicine in patients with Parkinson's disease and patients who are receiving high blood pressure medicines due to the increased risk of hypotension while getting up from a lying or sitting position. Close monitoring of blood pressure is necessary during treatment with this medicine. Patients are advised to get up slowly from a sitting or lying position to avoid these episodes.

Psychosis

Caution is advised while using this medicine in patients with a history of psychotic episodes due to the increased risk of worsening of the patient's condition. Patients should be monitored closely for any changes in mood or behavior.
Food interactions
Information not available.
Lab interactions
Information not available.
Take Parcar 1 mg Tablet following all the instructions on the leaflet or the package insert. Do not take in larger amounts than advised/prescribed. Consult the doctor if you experience any undesirable effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
Parcar 1 mg Tablet decreases the amount of prolactin in the body by blocking the excess production from the pituitary gland.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Dopamine agonists, Prolactin inhibitors

Schedule

Schedule H

Cabergoline: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 10 August 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a612020.html

Cabergoline: DrugBank [Internet]. Drugbank.ca. 2017 [cited 10 August 2017]. Available from:

https://www.drugbank.ca/drugs/DB00248

[Internet]. 2017 [cited 10 August 2017]. Available from:

https://www.medicines.org.uk/emc/medicine/1479

Cabergoline: cabergoline tablet [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 10 August 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0e2a2cb6-e453-4060-95f4-a8ce4ccecc10&audience=consumer

TOXNET [Internet]. Toxnet.nlm.nih.gov. 2017 [cited 10 August 2017]. Available from:

https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/f?./temp/~Y1b9zL:4

Cabergoline [Internet]. Snomedbrowser.com. 2017 [cited 10 August 2017]. Available from:

http://www.snomedbrowser.com/Codes/Details/386979007
Loading related questions...

How will this medicine affect me?

Chat with verified doctors starting @ ₹99
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Something doesn’t feel right?
Report an error